Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB9848 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB9848, RRID:AB_1673648
- Product name
- CX3CR1 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of CX3CR1.
- Storage
- Store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.
Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM
The Journal of biological chemistry 1998 Sep 11;273(37):23799-804
The Journal of biological chemistry 1998 Sep 11;273(37):23799-804
Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.
Combadiere C, Gao J, Tiffany HL, Murphy PM
Biochemical and biophysical research communications 1998 Dec 30;253(3):728-32
Biochemical and biophysical research communications 1998 Dec 30;253(3):728-32
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O
Cell 1997 Nov 14;91(4):521-30
Cell 1997 Nov 14;91(4):521-30
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis using CX3CR1 polyclonal antibody at 1 ug/mL on human spleen lysate in the absence (lane 1) and presence (lane 2) of specific blocking peptide.